Cellectis S.A.
CLLS • Biotechnology
$3.24
▼ -0.08 (-2.41%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$295.23M
Growth
5.2%
Cash Flow
1/5
Trend
Volatile
Evidence
Healthy liquidity · 1.62Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:48 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.24
Change-2.41%
Market Cap$295.23M
52W Range2.35 - 5.48
Beta2.90
Gross Margin86.57%
Oper. Margin-45.34%
Profit Margin-92.66%
Debt/Eq1.58
Current Ratio1.62
Quick Ratio1.62
Revenue 5Y5.24%
Price$3.24
Change-2.41%
Market Cap$295.23M
52W Range2.35 - 5.48
Beta2.90
Gross Margin86.57%
Oper. Margin-45.34%
Profit Margin-92.66%
Debt/Eq1.58
Current Ratio1.62
Quick Ratio1.62
Revenue 5Y5.24%
Target$9.00
Target Upside177.78%
Target Median$9.00
Target Range9.00 - 9.00
Volume12.00K
Avg Volume32.63K
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
38/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score▼
Healthy liquidity · 1.62Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$9.00
Mean
$9.00
Median
$9.00
High
$9.00
🧾
No insider activity
No recent insider transactions available.